JUNE SMITH-HARTNESS: Open Payments
NPI 1487609863 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,388 in 111 payments from 16 companies in 2025. Trend: 2023 $1,053 · 2024 $1,393 · 2025 $2,388
Food & beverage: $2,388
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $418 |
| Collegium Pharmaceutical, Inc. | 21 | $325 |
| ABBVIE INC. | 22 | $305 |
| Vanda Pharmaceuticals Inc. | 9 | $258 |
| Axsome Therapeutics, Inc. | 7 | $229 |
| Teva Pharmaceuticals USA, Inc. | 6 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 2 | $106 |
| Almatica Pharma LLC | 5 | $95 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
Products named: Jornay PM, VRAYLAR, ARISTADA, FANAPT, Auvelity, UZEDY, REXULTI, LYBALVI.
Industry payments across NC — which companies pay providers there.
